PharmChem Inc. [PharmChek Drugs of Abuse Sweat Patch] Revenue and Competitors
Employee Data
- PharmChem Inc. [PharmChek Drugs of Abuse Sweat Patch] has 46 Employees.
- PharmChem Inc. [PharmChek Drugs of Abuse Sweat Patch] grew their employee count by -4% last year.
PharmChem Inc. [PharmChek Drugs of Abuse Sweat Patch]'s People
Name | Title | Email/Phone |
---|
PharmChem Inc. [PharmChek Drugs of Abuse Sweat Patch] Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $300M | 7327 | 6% | N/A | N/A |
#2 | $7.5M | 151 | 5% | N/A | N/A |
#3 | $15M | 48 | 9% | N/A | N/A |
#4 | N/A | 71 | 1% | N/A | N/A |
#5 | $15M | 536 | 15% | N/A | N/A |
#6 | $15M | 109 | 33% | N/A | N/A |
#7 | $15M | 247 | 8% | N/A | N/A |
#8 | $3.5M | 41 | -2% | N/A | N/A |
#9 | $7.5M | 99 | 9% | N/A | N/A |
#10 | N/A | 25 | 14% | N/A | N/A |
What Is PharmChem Inc. [PharmChek Drugs of Abuse Sweat Patch]?
PharmChem Inc, based in Fort Worth, TX, holds the worldwide marketing and sole distribution rights to the FDA Cleared PharmChek® Drugs of Abuse Sweat Patch. The Sweat Patch uses sweat as the specimen source to test for Methamphetamine, Amphetamine, Cocaine, THC, PCP, and Opiates, in addition to offering an expanded panel for synthetic opiates. Worn on the body for 7-10 days, the Sweat Patch provides 24/7 monitoring for drugs of abuse. The wear-time can also be extended up to 14 monitoring days with the use of our Sweat Patch Overlay, (optional). The Sweat Patch technology is tamper evident, cannot be diluted, substituted, or adulterated without detection, and is confirmed by LC/MS/MS for both parent drug and drug metabolite.
keywords:N/AN/A
Total Funding
46
Number of Employees
N/A
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.7M | 46 | 21% | N/A |
#2 | $10.7M | 46 | -2% | N/A |
#3 | $11.8M | 46 | 5% | N/A |
#4 | $9.9M | 46 | 7% | N/A |
#5 | $9M | 46 | 7% | N/A |